Domainex Ltd wins biotechnology innovation award
Domainex
Dr Renos Savva, one of the company's founders and the CEO of Domainex, Dr Eddy Littler, received the award from Mr Andrew Cahn, CEO of UK Trade & Investment. "We are delighted to have been presented with this award, which recognises our commitment to developing new technologies for streamlining and accelerating the drug discovery process," said Dr Savva.
Domainex Ltd has developed a unique high-throughput technology for producing soluble and stable protein fragments that are suitable for compound screening, structural biology studies or antibody production. The approach resolves the discovery 'gap' that exists between the vast amount of genomic information that is now available, and the accessibility of the corresponding proteins for use in target validation and drug discovery.
Most read news
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.